Skip to content
4 min read

Milestone Monday: Out With A Stake, In With A Franchise: RedHill's Two-Day Reshuffle

The Israeli company sells its 70% Talicia stake to Apotex for $18m up front and pays Ferring $12m to bring in two revenue-generating gastrointestinal products, Rebyota and Clenpiq.

Silhouette of a suited executive at a curved balcony railing, looking out a tall office window in warm light.
Weighing the next move. Photo by Taylor Nicole on Unsplash.